Serum Packaging Sizes That Fit Retail vs Clinic Channels
Fifteen, thirty, fifty or a hundred milliliters: serum packaging sizes for retail brands are decided by shelf economics, while clinic packs are decided by cost per treatment, and…
Four derivatives, four different products, and one label that reads “vitamin C” on all of them. In a vitamin C derivatives serum the active you pick decides the pH window, the filling line, the packaging spec and the assay method — long before it decides the marketing copy. L-ascorbic acid at 15% and MAP at 15% are not the same claim, not the same stability program and not the same unit cost. This is the comparison we walk every brand through before a brief is locked, with the numbers we use on the bench.

L-ascorbic acid has to arrive on the skin as ascorbic acid to do what the literature describes. It is water-soluble, it is only stable below roughly pH 3.5, and it oxidises through dehydroascorbic acid into diketogulonic acid — the sequence that turns a clear serum orange in month four. Esters such as THD, MAP and SAP are not ascorbic acid in the bottle at all; they are salts or fatty esters that have to be hydrolysed in the skin before anything happens.
That single difference rewrites the whole specification. A 15% L-ascorbic formula at pH 3.0 needs deaerated water, a nitrogen blanket, a chelator and a 15-20% overage at the kettle, because some of it will be gone before the expiry date. A 3% MAP formula at pH 6.5 needs none of that — it survives a 70°C water phase and sits happily in a dropper. Same carton word, completely different factory.
There is also an assay trap. When we issue a COA for an ester-based vitamin C derivatives serum, the HPLC line reports the ester, not ascorbic acid, because that is what is in the vessel. If your supplier’s COA shows “ascorbic acid” on a THD or SAP batch, ask what method produced the number.
| Derivative | Form and INCI | Typical use level | pH window | Where it enters the batch | Packaging risk |
|---|---|---|---|---|---|
| L-Ascorbic Acid | Water-soluble acid | 10-20% | 2.6-3.5 | Water phase, added last, below 40°C, under nitrogen | High — needs airless and zero headspace |
| THD Ascorbate | Oil-soluble ester | 1-3%, up to 10% | No pH dependence | Oil phase, below 40°C, no high shear after addition | Low — a dropper is viable |
| MAP | Water-soluble salt | 3%, up to 12% | 6.0-7.5 | Water phase, tolerates 70°C | Low — dropper or pump |
| SAP | Water-soluble salt | 2-5%, up to 10% | 6.0-7.0 | Water phase, tolerates 70°C | Low — dropper or pump |
Read the table column by column, not row by row. No two of these four behave the same inside a vitamin C derivatives serum, and that is the whole point of the comparison. The pH window decides what else can go in the bottle: MAP and SAP sit comfortably next to niacinamide, while L-ascorbic at pH 3.0 does not, because niacinamide hydrolyses into nicotinic acid and the batch yellows with heat. Process order decides how long your batch stays open: the salts can go in with the water phase, which keeps a 500 kg run inside a normal single-shift fill window, while L-ascorbic forces a late, cold, protected addition and a fill inside 24 to 48 hours.
Solubility decides the chassis. THD is the only one of the four that works in an anhydrous oil serum, which is why it is the default when a brand wants a water-free story.
The right vitamin C derivatives serum for a given brand is usually decided by the market and the container, not by potency rankings on a supplier slide.
For a clinical-positioned brand selling an antioxidant claim, L-ascorbic acid with ferulic and tocopherol is still the honest answer, and our vitamin C serum platform already carries that chassis. For a sensitive-skin or barrier audience, SAP or MAP at 3-5% gets you a defensible brightening claim with almost no sting data. For acne-positioned lines, SAP has the more useful supporting literature. For a Gulf or Southeast Asia launch where a 40°C warehouse is normal, the ester route avoids the yellowing complaints that arrive six weeks after delivery.
If you want to blend vitamin C with niacinamide, the derivative choice is made for you — go ester or salt, keep pH above 6.0, and you can put both actives in one bottle without a color problem. If you want a two-phase product, the 12% MAP plus 4% niacinamide duo was built exactly for that brief, and it is the formula I hand to brands who ask for both actives in a single SKU.
The active is not always the expensive line, but with THD it is. These are the ranges from our recent rounds at a 30 ml fill, before container.
| Derivative at target level | Active cost per unit | Overage at the kettle | Added stabilizer cost | What drives the number |
|---|---|---|---|---|
| L-Ascorbic 15% | USD 0.02-0.04 | 15-20% | USD 0.01-0.02 | Overage plus the airless container |
| THD 3% | USD 0.20-0.45 | 0-5% | Negligible | Raw material price, nothing else comes close |
| MAP 3% | USD 0.05-0.12 | 5-10% | Not required | Assay and dossier work, not the powder |
| SAP 3% | USD 0.04-0.10 | 5-10% | Not required | Assay and dossier work |
A vitamin C derivatives serum built on THD can cost four to ten times the active cost of a MAP build before anyone has chosen a bottle. That is fine if the retail price supports it and the brand is selling the oil-soluble story. It is a slow way to lose margin if the brand is only selling “vitamin C”.
The minimum is the second cost lever, and it is the one brands underestimate. At 1,000 pcs per SKU, launching four derivatives as four SKUs means four stability programs, four carton artworks, four labels and four dossiers — roughly 4,000 units committed before you know which one sells. Our advice is usually to pick one derivative, run it properly, and add the second only once you have repeat-purchase data.
L-ascorbic is the benchmark, but it is the wrong backbone for a vitamin C derivatives serum in more situations than suppliers admit.
If the packaging is already bought and it is a clear dropper, do not build an L-ascorbic formula into it — every open-close cycle pulls in air, and a 30 ml dropper can move through 90 to 120 air exchanges over a three-month consumer period. If the target audience is sensitive or rosacea-prone, pH 3.0 stings, and the patch-test data will follow you into every market. If the shipping lane runs through a hot, humid warehouse, the oxidation rate climbs with temperature and you will see returns for color change rather than for performance. And if the brand wants to stack niacinamide, peptide or copper actives in the same bottle, low pH is a chemical obstacle, not a preference.
What you give up by leaving L-ascorbic is claim strength. Ascorbic acid still owns the deepest published evidence base. SAP, MAP and THD can carry brightening and antioxidant support with careful wording, but a brand that wants to cite clinical ascorbic acid work needs the acid.
The differences above turn into three concrete line decisions for any vitamin C derivatives serum.
First, the water phase. For L-ascorbic we run the process water through deaeration, hold the batch under nitrogen, dissolve the ferulic and tocopherol in the oil phase, then add ascorbic acid after the emulsion has cooled below 40°C on low-shear mixing only. For MAP and SAP we can charge the water phase at up to 70°C, which makes the run faster and cheaper. For THD we keep the oil phase separate at 60-65°C, cool before addition, and avoid high-shear homogenisation after the ester goes in, because shear with heat is what damages the ester.
Second, the stability program. Every derivative gets the same skeleton — 12 weeks at 40°C and 75% relative humidity, plus real-time data at 25°C — but the pass criteria differ. An L-ascorbic build with ferulic acid is judged on color and assay retention, and it holds within 10-15% of label over 12 weeks in an airless pump. A 20% THD anhydrous oil serum is judged almost purely on assay, because there is no water for color to track against. Both are assayed by HPLC at release and again at the end of the accelerated program; a label claim that is not assayed at both points is a number with nothing behind it.
Third, the documents. Every batch leaves with a COA, an MSDS, the full INCI and a Certificate of Free Sale, produced under ISO 22716 and GMPC with filling in an ISO 8 cleanroom. The full set is on the compliance page we hand to buyers, and if your market needs CPNP for the EU or SCPN for the UK, that filing sits on top of those documents and belongs to your importer. Sampling is 7 days, bulk is 35 days from brief approval, and the minimum is 1,000 pcs per SKU — the same terms whichever derivative you choose.
If you would rather not build a chassis from zero, the 24 formulas in our library already cover all four derivatives and have been through the chamber, so we start from a known-good base and adjust for your market.
You can, and it is often the best of both — an ester or salt for the stable backbone and a small dose of L-ascorbic for the acid claim. Blending two pH-dependent actives is where it breaks, so keep the acid variant on its own chassis unless the whole formula can sit below pH 3.5.
Not proportionally. The salt has to hydrolyse before it acts, and the conversion is not one-to-one by mass. A 5% SAP build is a sensible ceiling for a retail launch; beyond that you are buying weight, not measurable effect.
The salts, MAP and SAP, by a wide margin, because they tolerate neutral pH and heat. L-ascorbic has the best efficacy data and the worst stability profile. THD sits in the middle — excellent in an anhydrous base, and it needs care in an emulsion.
Usually headspace. A clear dropper bottle, a partial fill, or a batch filled more than 48 hours after the ascorbic addition will all oxidise ahead of schedule. Fix the container before you blame the percentage.
—
Send us your brief with your target market, container and claim, and we will come back with a derivative recommendation, a formula and a unit price within 48 hours. Samples are 7 days, bulk is 35 days, and the minimum is 1,000 pcs per SKU.